REGULATION OF C-SRC PREMRNA SPLICING

C-SRC 前体 RNA 剪接的调控

基本信息

  • 批准号:
    2701594
  • 负责人:
  • 金额:
    $ 13.52万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1993
  • 资助国家:
    美国
  • 起止时间:
    1993-08-01 至 2002-07-31
  • 项目状态:
    已结题

项目摘要

Alternative splicing is an important means of genetic control in eucaryotic cells. By altering the splicing pattern of the primary transcript, a variety of proteins can be created from a single gene. Alternative splicing is especially prominent in the mammalian nervous system, where it regulates the production of many proteins that are important for neuronal development, function, and disease. Unfortunately, although our understanding of the general biochemistry of splicing has advanced significantly, much less is known of how splicing is regulated. The mouse c-src gene has provided an effective model system for studying a neuron-specific splicing event. Neurons produce a different form of the src protein from other tissues, resulting from the neuron-specific insertion of an extra exon (the N1 exon) into the src mRNA. Two major cis-acting elements that control N1 splicing have been identified by site specific mutagenesis of a transfected src mini-gene. These are an intronic splicing enhancer, downstream of N1, that activates splicing of the exon but is only partially neural specific, and the 3' splice site upstream of the exon that represses the splicing in non-neuronal cells. The combination of these two sequences confers neural specific splicing on a heterologous test exon. The regulated splicing of the N1 exon was reconstituted in extracts of neuronal and non-neuronal cells and some of the regulatory proteins have been identified. These include the KSRP, hnRNP F, hnRNP H and PTB proteins binding to the downstream enhancer, and the PTB protein also binding to the upstream 3' splice site. How the RNA/protein complexes at these sites combine to generate the precise tissue specific inclusion of an exon is still unclear. This project will pursue the molecular analysis of src neuron-specific splicing. Using a variety of biochemical assays, the assembly of the regulatory proteins onto the enhancer and repressor RNA sequences will be studied, and the interactions of these RNA/protein complexes with each other, and with components of the spliceosome will be dissected. New regulatory proteins will be characterized, including a neural specific form of PTB. The role of the recently described splicing enhancer protein, KSRP, will be studied and the functional domains of the protein delineated. Finally, simplified splicing systems will be developed for the analysis of individual regulatory proteins. Our goal is to understand in molecular detail how a simple change in splicing pattern is regulated in differentiated cells.
选择性剪接是一种重要的遗传控制手段, 真核细胞 通过改变主细胞的拼接模式 转录本,多种蛋白质可以从一个单一的基因创建。 选择性剪接在哺乳动物的神经系统中尤为突出。 系统,在那里它调节许多蛋白质的产生, 对神经元发育、功能和疾病都很重要。 不幸的是,尽管我们对普通生物化学的理解 拼接的技术已经有了很大的进步,但人们对如何拼接知之甚少。 剪接受到调节。小鼠c-src基因提供了有效的 用于研究神经元特异性剪接事件的模型系统。 神经元 产生与其他组织不同形式的src蛋白, 这是由于神经元特异性插入一个额外的外显子(N1 外显子)插入src mRNA中。 控制N1的两个主要顺式作用元件 剪接已经通过对一个突变位点的位点特异性诱变来鉴定, 转染src mini-gene。 这些是内含子剪接增强子 N1的下游,激活外显子的剪接,但仅 部分神经特异性,外显子上游的3'剪接位点 抑制非神经元细胞的剪接。的组合 这两个序列赋予神经特异性剪接在异源 测试外显子。 N1外显子的受调控剪接被重建, 神经元和非神经元细胞的提取物以及一些调节性的 蛋白质已被鉴定。 其中包括KSRP、hnRNP F、hnRNP H和PTB蛋白结合到下游增强子,并且PTB 蛋白质也结合到上游3'剪接位点。 如何 这些位点上的RNA/蛋白质复合物联合收割机产生精确的 外显子的组织特异性包含仍不清楚。该项目将 进行src神经元特异性剪接的分子分析。 使用 各种生化分析,调节蛋白的组装 将研究增强子和阻遏子RNA序列, 这些RNA/蛋白质复合物彼此之间的相互作用,以及 剪接体的组分将被解剖。 新的监管 蛋白质将被表征,包括PTB的神经特异性形式。 最近描述的剪接增强子蛋白KSRP的作用, 研究和蛋白质的功能域划定。 最后,将开发用于分析的简化拼接系统 单个调节蛋白。我们的目标是了解 剪接模式的简单变化是如何被调控的分子细节 在分化的细胞中。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Douglas L Black其他文献

Douglas L Black的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Douglas L Black', 18)}}的其他基金

Comprehensive Maps of U1 snRNP Binding to Nascent RNA in Human Cells
U1 snRNP 与人类细胞中新生 RNA 结合的综合图谱
  • 批准号:
    10507429
  • 财政年份:
    2022
  • 资助金额:
    $ 13.52万
  • 项目类别:
Mechanisms of Post-transcriptional Gene Regulation by PTB and Rbfox Proteins
PTB 和 Rbfox 蛋白转录后基因调控机制
  • 批准号:
    10362546
  • 财政年份:
    2020
  • 资助金额:
    $ 13.52万
  • 项目类别:
Mechanisms of Post-transcriptional Gene Regulation by PTB and Rbfox Proteins
PTB 和 Rbfox 蛋白转录后基因调控机制
  • 批准号:
    10797969
  • 财政年份:
    2020
  • 资助金额:
    $ 13.52万
  • 项目类别:
Mechanisms of Post-transcriptional Gene Regulation by PTB and Rbfox Proteins
PTB 和 Rbfox 蛋白转录后基因调控机制
  • 批准号:
    10810036
  • 财政年份:
    2020
  • 资助金额:
    $ 13.52万
  • 项目类别:
Mechanisms of Post-transcriptional Gene Regulation by PTB and Rbfox Proteins
PTB 和 Rbfox 蛋白转录后基因调控机制
  • 批准号:
    10589873
  • 财政年份:
    2020
  • 资助金额:
    $ 13.52万
  • 项目类别:
Multi-omic analysis of Myc-driven splicing for prostate cancer therapeutic development
Myc 驱动剪接的多组学分析用于前列腺癌治疗开发
  • 批准号:
    9898152
  • 财政年份:
    2018
  • 资助金额:
    $ 13.52万
  • 项目类别:
Multi-omic analysis of Myc-driven splicing for prostate cancer therapeutic development
Myc 驱动剪接的多组学分析用于前列腺癌治疗开发
  • 批准号:
    10364684
  • 财政年份:
    2018
  • 资助金额:
    $ 13.52万
  • 项目类别:
Elucidating an Xist-dependent program of sexually dimorphic alternative splicing in the mammalian brain
阐明哺乳动物大脑中依赖于 Xist 的性二态选择性剪接程序
  • 批准号:
    9305157
  • 财政年份:
    2016
  • 资助金额:
    $ 13.52万
  • 项目类别:
Elucidating an Xist-dependent program of sexually dimorphic alternative splicing in the mammalian brain
阐明哺乳动物大脑中依赖于 Xist 的性二态选择性剪接程序
  • 批准号:
    9922380
  • 财政年份:
    2016
  • 资助金额:
    $ 13.52万
  • 项目类别:
Mechanisms of Alternative Splicing Regulation by Rbfox Proteins
Rbfox 蛋白的选择性剪接调控机制
  • 批准号:
    9353837
  • 财政年份:
    2016
  • 资助金额:
    $ 13.52万
  • 项目类别:

相似海外基金

Mechanisms of messenger RNA splicing and RNA processing regulation
信使RNA剪接和RNA加工调控机制
  • 批准号:
    10623834
  • 财政年份:
    2023
  • 资助金额:
    $ 13.52万
  • 项目类别:
Analysis on how RNA splicing factors change global gene expression patterns and regulate male fertility.
分析RNA剪接因子如何改变全局基因表达模式并调节男性生育能力。
  • 批准号:
    2882792
  • 财政年份:
    2023
  • 资助金额:
    $ 13.52万
  • 项目类别:
    Studentship
Collaborative Research: Connecting the sequence logic of RNA splicing to nuclear localization
合作研究:将 RNA 剪接的序列逻辑与核定位联系起来
  • 批准号:
    2246530
  • 财政年份:
    2023
  • 资助金额:
    $ 13.52万
  • 项目类别:
    Standard Grant
Collaborative Research: Connecting the sequence logic of RNA splicing to nuclear localization
合作研究:将 RNA 剪接的序列逻辑与核定位联系起来
  • 批准号:
    2246531
  • 财政年份:
    2023
  • 资助金额:
    $ 13.52万
  • 项目类别:
    Standard Grant
Aberrant RNA splicing in sporadic inclusion body myositis
散发性包涵体肌炎中的异常RNA剪接
  • 批准号:
    23K18260
  • 财政年份:
    2023
  • 资助金额:
    $ 13.52万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Synthetic introns for selective targeting of RNA splicing factor-mutant leukemia
用于选择性靶向RNA剪接因子突变型白血病的合成内含子
  • 批准号:
    10722782
  • 财政年份:
    2023
  • 资助金额:
    $ 13.52万
  • 项目类别:
Cancer immune therapeutics targeting aberrant RNA splicing products
针对异常 RNA 剪接产物的癌症免疫疗法
  • 批准号:
    23H02688
  • 财政年份:
    2023
  • 资助金额:
    $ 13.52万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
RNA splicing regulation during alcohol withdrawal
酒精戒断过程中的 RNA 剪接调节
  • 批准号:
    10785159
  • 财政年份:
    2023
  • 资助金额:
    $ 13.52万
  • 项目类别:
Targeting Dysregulated RNA Splicing in Neurodegenerative Diseases
靶向神经退行性疾病中失调的 RNA 剪接
  • 批准号:
    10729566
  • 财政年份:
    2023
  • 资助金额:
    $ 13.52万
  • 项目类别:
Function, composition, and mechanism of RNA splicing factories in cardiomyopathy
RNA剪接工厂在心肌病中的功能、组成和机制
  • 批准号:
    10583011
  • 财政年份:
    2022
  • 资助金额:
    $ 13.52万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了